SCHWAB CHARLES CORP (SCHW-PJ) Insider Transactions
Explore official ownership filings, with every record linked to its source.
SCHW-PJ · SCHWAB CHARLES CORP
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-11-10Filed 2026-11-10 | Schwab Charles R.Director · Officer · Co-ChairmanFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This transaction was executed in multiple trades at prices ranging from $92.835 to $93.135. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. References: | G GiftCommon Stock · Non-derivative | 31,850D | 0 | Indirectby Trust | Form 4 ↗0000923738-26-000052 |
| 2026-11-09Filed 2026-11-10 | Schwab Charles R.Director · Officer · Co-ChairmanFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This transaction was executed in multiple trades at prices ranging from $92.835 to $93.135. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 70,750D | 93.0074 | Indirectby Trust | Form 4 ↗0000923738-26-000052 |
| 2026-11-03Filed 2026-11-05 | Schwab Charles R.Director · Officer · Co-ChairmanFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This transaction was executed in multiple trades at prices ranging from $89.115 to $89.30. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 11,675D | 89.2149 | Indirectby Trust | Form 4 ↗0000923738-26-000050 |
| 2026-11-02Filed 2026-11-03 | Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, TstFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of the shares received upon exercise of the option to a trust. F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F3 This transaction was executed in multiple trades at prices ranging from $88.49 to $89.24. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F4 | M Exercise / conversionNonqualified Stock Option (right to buy) · Derivative | 5,000D | 0 | Direct | Form 4 ↗0001879974-26-000017 |
| 2026-11-02Filed 2026-11-03 | Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, TstFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of the shares received upon exercise of the option to a trust. F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F3 This transaction was executed in multiple trades at prices ranging from $88.49 to $89.24. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F2, F3, F1 | S Sale (market/private)Common Stock · Non-derivative | 5,000D | 88.9236 | Indirectby Trust | Form 4 ↗0001879974-26-000017 |
| 2026-11-02Filed 2026-11-03 | Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, TstFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of the shares received upon exercise of the option to a trust. F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F3 This transaction was executed in multiple trades at prices ranging from $88.49 to $89.24. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 5,000A | 64.1 | Direct | Form 4 ↗0001879974-26-000017 |
| 2026-10-29Filed 2026-10-29 | Schwab Charles R.Director · Officer · Co-ChairmanFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This transaction was executed in multiple trades at prices ranging from $88.185 to $88.59. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F2 This transaction was executed in multiple trades at prices ranging from $89.06 to $89.92. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. References: F2 | S Sale (market/private)Common Stock · Non-derivative | 136,400D | 89.5005 | Indirectby Trust | Form 4 ↗0000923738-26-000048 |
| 2026-10-28Filed 2026-10-29 | Schwab Charles R.Director · Officer · Co-ChairmanFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This transaction was executed in multiple trades at prices ranging from $88.185 to $88.59. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F2 This transaction was executed in multiple trades at prices ranging from $89.06 to $89.92. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 66,750D | 88.3559 | Indirectby Trust | Form 4 ↗0000923738-26-000048 |
| 2026-10-01Filed 2026-10-05 | Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, TstFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of the shares received upon exercise of the option to a trust. F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F3 This transaction was executed in multiple trades at prices ranging from $97.275 to $98.23. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F4 | M Exercise / conversionNonqualified Stock Option (right to buy) · Derivative | 5,000D | 0 | Direct | Form 4 ↗0001879974-26-000015 |
| 2026-10-01Filed 2026-10-05 | Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, TstFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of the shares received upon exercise of the option to a trust. F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F3 This transaction was executed in multiple trades at prices ranging from $97.275 to $98.23. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F2, F3, F1 | S Sale (market/private)Common Stock · Non-derivative | 5,000D | 97.8014 | Indirectby Trust | Form 4 ↗0001879974-26-000015 |
| 2026-10-01Filed 2026-10-05 | Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, TstFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of the shares received upon exercise of the option to a trust. F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F3 This transaction was executed in multiple trades at prices ranging from $97.275 to $98.23. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 5,000A | 41.98 | Direct | Form 4 ↗0001879974-26-000015 |
| 2026-10-01Filed 2026-10-05 | Brown Marianne CatherineDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit ("RSU") represents a right to receive one share of company stock. F2 The RSUs were received pursuant to the Directors' Deferred Compensation Plan II (the "Plan") and are held in a rabbi trust for the benefit of the reporting person pursuant to the terms of the Plan. F3 The RSUs are held in a rabbi trust for the benefit of the reporting person and are distributed to the reporting person when she leaves the Board of Directors. F4 The RSUs were received in lieu of cash compensation otherwise payable as director fees. F5 Includes 23.85 RSUs acquired through dividend reinvestment. References: F1, F2, F4, F3, F5 | A Award / grantRestricted Stock Units · Derivative | 407A | — | Direct | Form 4 ↗0001804183-26-000016 |
| 2026-10-01Filed 2026-10-05 | Ruffel Charles A.DirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The option was received pursuant to the Directors' Compensation Plan II and vested immediately. F2 The option was received in lieu of cash compensation otherwise payable as director fees. References: F2, F1 | A Award / grantNonqualified Stock Option (right to buy) · Derivative | 1,222A | 0 | Direct | Form 4 ↗0001739929-26-000010 |
| 2026-10-01Filed 2026-10-05 | Ellis Stephen ADirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit ("RSU") represents a right to receive one share of company stock. F2 The RSUs were received pursuant to the Directors' Deferred Compensation Plan II (the "Plan") and are held in a rabbi trust for the benefit of the reporting person pursuant to the terms of the Plan. F3 The RSUs are held in a rabbi trust for the benefit of the reporting person and are distributed to the reporting person when he leaves the Board of Directors. F4 The RSUs were received in lieu of cash compensation otherwise payable as director fees. F5 Includes 38.29 RSUs acquired through dividend reinvestment. References: F1, F2, F4, F3, F5 | A Award / grantRestricted Stock Units · Derivative | 369A | — | Direct | Form 4 ↗0001561563-26-000025 |
| 2026-10-01Filed 2026-10-05 | HERRINGER FRANK CDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit ("RSU") represents a right to receive one share of company stock. F2 The RSUs were received pursuant to the Directors' Deferred Compensation Plan II (the "Plan") and are held in a rabbi trust for the benefit of the reporting person pursuant to the terms of the Plan. F3 The RSUs are held in a rabbi trust for the benefit of the reporting person and are distributed to the reporting person when he leaves the Board of Directors. F4 The RSUs were received in lieu of cash compensation otherwise payable as director fees. F5 Includes 440.52 RSUs acquired through dividend reinvestment. References: F1, F2, F4, F3, F5 | A Award / grantRestricted Stock Units · Derivative | 445A | — | Direct | Form 4 ↗0001171694-26-000012 |
| 2026-09-23Filed 2026-09-25 | Ellis Stephen ADirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of shares received upon exercise of the option to a trust. F2 Includes 299.7567 shares acquired through dividend reinvestment. F3 The option was received pursuant to the Directors' Deferred Compensation Plan II and vested immediately. References: F3 | M Exercise / conversionNonqualified Stock Option (right to buy) · Derivative | 1,918D | 0 | Direct | Form 4 ↗0001561563-26-000023 |
| 2026-09-23Filed 2026-09-25 | Ellis Stephen ADirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of shares received upon exercise of the option to a trust. F2 Includes 299.7567 shares acquired through dividend reinvestment. F3 The option was received pursuant to the Directors' Deferred Compensation Plan II and vested immediately. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 1,918A | 31.48 | Direct | Form 4 ↗0001561563-26-000023 |
| 2026-09-01Filed 2026-09-02 | Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, TstFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of the shares received upon exercise of the option to a trust. F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F3 This transaction was executed in multiple trades at prices ranging from $108.51 to $109.50. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F4 | M Exercise / conversionNonqualified Stock Option (right to buy) · Derivative | 3,177D | 0 | Direct | Form 4 ↗0001879974-26-000013 |
| 2026-09-01Filed 2026-09-02 | Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, TstFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of the shares received upon exercise of the option to a trust. F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F3 This transaction was executed in multiple trades at prices ranging from $108.51 to $109.50. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F2, F3, F1 | S Sale (market/private)Common Stock · Non-derivative | 3,177D | 109.0425 | Indirectby Trust | Form 4 ↗0001879974-26-000013 |
| 2026-09-01Filed 2026-09-02 | Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, TstFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of the shares received upon exercise of the option to a trust. F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026. F3 This transaction was executed in multiple trades at prices ranging from $108.51 to $109.50. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 3,177A | 52.05 | Direct | Form 4 ↗0001879974-26-000013 |
| 2026-08-28Filed 2026-08-31 | Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, TstFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of the shares received upon exercise of the option to a trust. F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on May 29, 2026. F3 This transaction was executed in multiple trades at prices ranging from $107.805 to $108.725. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F4 | M Exercise / conversionNonqualified Stock Option (right to buy) · Derivative | 3,177D | 0 | Direct | Form 4 ↗0001879974-26-000010 |
| 2026-08-28Filed 2026-08-31 | Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, TstFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of the shares received upon exercise of the option to a trust. F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on May 29, 2026. F3 This transaction was executed in multiple trades at prices ranging from $107.805 to $108.725. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F2, F3, F1 | S Sale (market/private)Common Stock · Non-derivative | 3,177D | 108.1201 | Indirectby Trust | Form 4 ↗0001879974-26-000010 |
| 2026-08-28Filed 2026-08-31 | Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, TstFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects the contribution of the shares received upon exercise of the option to a trust. F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on May 29, 2026. F3 This transaction was executed in multiple trades at prices ranging from $107.805 to $108.725. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F1 | M Exercise / conversionCommon Stock · Non-derivative | 3,177A | 52.05 | Direct | Form 4 ↗0001879974-26-000010 |
| 2026-08-28Filed 2026-08-31 | Bettinger Walter WDirector · Officer · Co-ChairmanFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This transaction was executed in multiple trades at prices ranging from $110.90 to $110.98. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F2 Includes 7.0627 shares acquired through dividend reinvestment. F3 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F3 | M Exercise / conversionNonqualified Stock Option (right to buy) · Derivative | 74,388D | 0 | Direct | Form 4 ↗0001296479-26-000014 |
| 2026-08-28Filed 2026-08-31 | Bettinger Walter WDirector · Officer · Co-ChairmanFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 This transaction was executed in multiple trades at prices ranging from $110.90 to $110.98. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F2 Includes 7.0627 shares acquired through dividend reinvestment. F3 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 74,388D | 110.9137 | Indirectby Family Trust | Form 4 ↗0001296479-26-000014 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.